Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rieckmann

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
European Journal of Neurology|August 2, 2005
The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple sclerosis: 4-year data from the PRISMS studyR Gold, P Rieckmann, P Chang, et al.
Journal of Neurology|July 28, 2007
Orthostatic tremor in three brothersM Fischer, W Kress, K Reiners, et al.
European Neurology|January 1, 1996
Acute inflammatory CNS disease after MDMA ('ecstasy')A Bitsch, A Thiel, P Rieckmann, et al.
Biochemical and Biophysical Research Communications|April 25, 2000
Differential expression of sense and antisense transcripts of the mitochondrial DNA region coding for ATPase 6 in fetal and adult porcine brain: identification of novel unusually assembled mitochondrial RNAsU Michel, A K Stringaris, R Nau, et al.
Der Nervenarzt|March 21, 2001
[Treatment of relapsing-remitting multiple sclerosis with recombinant interferon-beta preparations]M Mäurer, R Gold, K V Toyka, et al.
Der Nervenarzt|September 14, 1999
[Mitoxantrone (Novantron) in therapy of severe multiple sclerosis. A retrospective study of 15 patients]S Cursiefen, P Flachenecker, P Rieckmann, et al.
European Neurology|April 15, 2000
Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosisS Cursiefen, P Flachenecker, K V Toyka, et al.
Lancet (London, England)|August 26, 1998
Telencephalin as an indicator for temporal-lobe dysfunctionP Rieckmann, T Turner, P Kligannon, et al.
Analytical Biochemistry|February 4, 1998
A method for preventing artifactual binding of cRNA probes to neurons caused by in situ hybridizationB Blödorn, W Brück, P Rieckmann, et al.
Annals of Neurology|March 1, 1997
Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosisP Rieckmann, B Altenhofen, A Riegel, et al.
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
European Journal of Neurology|August 2, 2005
The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple sclerosis: 4-year data from the PRISMS studyR Gold, P Rieckmann, P Chang, et al.
Journal of Neurology|July 28, 2007
Orthostatic tremor in three brothersM Fischer, W Kress, K Reiners, et al.
European Neurology|January 1, 1996
Acute inflammatory CNS disease after MDMA ('ecstasy')A Bitsch, A Thiel, P Rieckmann, et al.
Biochemical and Biophysical Research Communications|April 25, 2000
Differential expression of sense and antisense transcripts of the mitochondrial DNA region coding for ATPase 6 in fetal and adult porcine brain: identification of novel unusually assembled mitochondrial RNAsU Michel, A K Stringaris, R Nau, et al.
Der Nervenarzt|March 21, 2001
[Treatment of relapsing-remitting multiple sclerosis with recombinant interferon-beta preparations]M Mäurer, R Gold, K V Toyka, et al.
Der Nervenarzt|September 14, 1999
[Mitoxantrone (Novantron) in therapy of severe multiple sclerosis. A retrospective study of 15 patients]S Cursiefen, P Flachenecker, P Rieckmann, et al.
European Neurology|April 15, 2000
Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosisS Cursiefen, P Flachenecker, K V Toyka, et al.
Lancet (London, England)|August 26, 1998
Telencephalin as an indicator for temporal-lobe dysfunctionP Rieckmann, T Turner, P Kligannon, et al.
Analytical Biochemistry|February 4, 1998
A method for preventing artifactual binding of cRNA probes to neurons caused by in situ hybridizationB Blödorn, W Brück, P Rieckmann, et al.
Annals of Neurology|March 1, 1997
Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosisP Rieckmann, B Altenhofen, A Riegel, et al.
Pageof 15